[Skip to Navigation]
Views 1,039
Citations 0
Research Letter
November 25, 2020

Trends in Hospitalizations for Heart Failure and Ischemic Heart Disease Among US Adults With Diabetes

Author Affiliations
  • 1Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston
  • 2Division of Cardiology, Feinberg School of Medicine, Department of Medicine, Northwestern University, Chicago, Illinois
  • 3Division of Cardiology, Department of Internal Medicine, The University of Texas Southwestern Medical Center and Parkland Health & Hospital System, Dallas
  • 4Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles
  • 5Associate Editor for Health Care Quality and Guidelines, JAMA Cardiology
  • 6Department of Medicine, University of Mississippi Medical Center, Jackson
  • 7Brigham and Women’s Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts
JAMA Cardiol. 2021;6(3):354-357. doi:10.1001/jamacardio.2020.5921

Historically, prevention strategies for patients with diabetes have focused on microvascular complications and atherosclerotic cardiovascular disease; however, diabetes is now recognized to confer broad health effects, including a more than 2-fold excess risk of incident heart failure (HF)1 via biological pathways beyond atherothrombosis alone. Risk stratification tools2 and preventive strategies differ for HF and atherosclerotic cardiovascular disease in patients with diabetes—for example, sodium-glucose cotransporter 2 inhibitors can powerfully mitigate HF risk3—yet national US data characterizing the burden of and temporal trends in HF compared with ischemic heart disease (IHD) among patients with diabetes are limited.